)
Edge
Extra Everything: The Story of Chipotle
Chipotle's story from a single restaurant to a nationwide chain, through crisis and turnaround, built on one of the strongest models in the industry.
PTC Therapeutics
PTC Therapeutics (PTCT) investor relations material
PTC Therapeutics Corporate presentation summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Corporate presentation summary10 May, 2026
Strategic focus and execution in 2025
Achieved US, EU, and Japan approvals for Sephience and initiated a strong global launch.
Exceeded 2025 revenue guidance with $831M in total revenue, including $587M in product revenue.
Advanced early-stage R&D programs and managed operating expenses effectively.
Sephience launch and performance
Generated $125M in Q1 2026 global revenue for Sephience, with $112M from the US and $13M ex-US.
1,244 patients on commercial therapy worldwide as of March 31, 2026.
Anticipates commercial patients in up to 30 countries by year-end 2026.
Product differentiation and market potential
Sephience’s dual mechanism of action supports broad uptake, significantly increasing intracellular BH4 levels.
Demonstrated 70.3% greater reduction in blood Phe compared to BH4 in clinical studies.
Provided meaningful diet liberalization, cognitive, and quality of life benefits in extension studies.
Positioned to penetrate all key PKU market segments, with a total addressable market of 17,000 US patients.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from PTC Therapeutics
- Sephience's launch drove 47% revenue growth and a raised 2026 outlook, despite a net loss.PTCT
Q1 20268 May 2026 - Votoplam slowed Huntington's disease progression by up to 52% at 24 months with sustained safety.PTCTStudy result28 Apr 2026
- Election of directors, auditor ratification, and say-on-pay up for vote at June 2026 meeting.PTCTProxy filing20 Apr 2026
- 2026 meeting covers director elections, auditor ratification, and performance-based executive pay.PTCTProxy filing20 Apr 2026
- 2025 revenue and net income surged on Sephience uptake and Novartis deal; 2026 growth expected.PTCTQ4 202512 Apr 2026
- Sephience drives robust growth and pipeline expansion, with strong launch momentum and broad R&D progress.PTCTLeerink Global Healthcare Conference 202624 Mar 2026
- Sepiapterin’s rapid global launch drives strong PKU adoption and robust pipeline momentum.PTCTBarclays 28th Annual Global Healthcare Conference20 Mar 2026
- Sephience's launch accelerates growth, with pipeline and global expansion fueling future momentum.PTCTTD Cowen 46th Annual Health Care Conference2 Mar 2026
- Surpassed 2025 revenue targets and set ambitious 2026 growth and R&D milestones.PTCTCorporate presentation27 Feb 2026
Next PTC Therapeutics earnings date
Bank of America Global Healthcare Conference 202612 May, 2026
PTC Therapeutics
Next PTC Therapeutics earnings date
Bank of America Global Healthcare Conference 202612 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
)
Frequently asked questions
Explore our global coverage